Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 191

1.

Drug-induced injury due to flucloxacillin: relevance of multiple HLA alleles.

Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI, Andrade RJ, Bjornsson E, Dillon JF, Hallberg P, Lucena MI, Maitland van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Wadelius M, Shen Y, Nelson MR, Daly AK; International Drug-induced Liver Injury consortium (iDILIC).

Clin Pharmacol Ther. 2019 Jan 19. doi: 10.1002/cpt.1375. [Epub ahead of print]

PMID:
30661239
2.

Precision medicine in childhood asthma.

Slob EM, Maitland-Van der Zee AH, Koppelman GH, Pijnenburg MW.

Curr Opin Allergy Clin Immunol. 2019 Jan 14. doi: 10.1097/ACI.0000000000000517. [Epub ahead of print]

PMID:
30649013
3.

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review.

Keskin O, Farzan N, Birben E, Akel H, Karaaslan C, Maitland-van der Zee AH, Wechsler ME, Vijverberg SJ, Kalayci O.

Clin Transl Allergy. 2019 Jan 9;9:2. doi: 10.1186/s13601-018-0239-2. eCollection 2019. Review.

4.

Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma.

Brinkman P, Wagener AH, Hekking PP, Bansal AT, Maitland-van der Zee AH, Wang Y, Weda H, Knobel HH, Vink TJ, Rattray NJ, D'Amico A, Pennazza G, Santonico M, Lefaudeux D, De Meulder B, Auffray C, Bakke PS, Caruso M, Chanez P, Chung KF, Corfield J, Dahlén SE, Djukanovic R, Geiser T, Horvath I, Krug N, Musial J, Sun K, Riley JH, Shaw DE, Sandström T, Sousa AR, Montuschi P, Fowler SJ, Sterk PJ; U-BIOPRED Study Group.

J Allergy Clin Immunol. 2018 Dec 6. pii: S0091-6749(18)31722-6. doi: 10.1016/j.jaci.2018.10.058. [Epub ahead of print]

PMID:
30529449
5.

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltrán L, Jiménez-Varo E, Cañadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genç E, Özer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.

Clin Pharmacol Ther. 2018 Dec 2. doi: 10.1002/cpt.1323. [Epub ahead of print]

PMID:
30506689
6.

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review.

Zazuli Z, Vijverberg S, Slob E, Liu G, Carleton B, Veltman J, Baas P, Masereeuw R, Maitland-van der Zee AH.

Front Pharmacol. 2018 Sep 27;9:1111. doi: 10.3389/fphar.2018.01111. eCollection 2018.

7.

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.

Oshagbemi OA, Franssen FME, Braeken DCW, Henskens Y, Wouters EFM, Maitland-van der Zee AH, Burden AM, de Vries F.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1191-1199. doi: 10.1002/pds.4655. Epub 2018 Sep 28.

8.

Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJ, Appel IM, Tamminga RY, Cessie SL, Swen JJ, der Straaten TV, Boer A, Maitland-van der Zee AH.

Pharmacogenomics. 2018 Oct;19(15):1195-1202. doi: 10.2217/pgs-2018-0095. Epub 2018 Sep 12.

PMID:
30207196
9.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

PMID:
30179741
10.

AsthmaMap: An expert-driven computational representation of disease mechanisms.

Mazein A, Knowles RG, Adcock I, Chung KF, Wheelock CE, Maitland-van der Zee AH, Sterk PJ, Auffray C; AsthmaMap Project Team.

Clin Exp Allergy. 2018 Aug;48(8):916-918. doi: 10.1111/cea.13211. No abstract available.

PMID:
30133857
11.

Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.

Slob EMA, Vijverberg SJH, Palmer CNA, Zazuli Z, Farzan N, Oliveri NMB, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH.

Pediatr Allergy Immunol. 2018 Nov;29(7):705-714. doi: 10.1111/pai.12956. Epub 2018 Aug 12. Review.

PMID:
29992699
12.

AdDIT Editorial comment-challenges in medication treatment of renal and cardiovascular diseases and risk factors in adolescents with type 1 diabetes.

Ahmadizar F, Maitland-van der Zee AH.

Ann Transl Med. 2018 May;6(10):193. doi: 10.21037/atm.2018.03.25. No abstract available.

13.

Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.

Mahmoudpour SH, Asselbergs FW, Souverein PC, de Boer A, Maitland-van der Zee AH.

Br J Clin Pharmacol. 2018 Oct;84(10):2365-2372. doi: 10.1111/bcp.13692. Epub 2018 Jul 24.

PMID:
29943849
14.

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, le Cessie S, Swen JJ, van der Straaten T, de Boer A, Maitland-van der Zee AH.

J Thromb Haemost. 2018 Sep;16(9):1732-1742. doi: 10.1111/jth.14211. Epub 2018 Jul 17.

PMID:
29935043
15.

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use.

Farzan N, Vijverberg SJ, Hernandez-Pacheco N, Bel EHD, Berce V, Bønnelykke K, Bisgaard H, Burchard EG, Canino G, Celedón JC, Chew FT, Chiang WC, Cloutier MM, Forno E, Francis B, Hawcutt DB, Herrera-Luis E, Kabesch M, Karimi L, Melén E, Mukhopadhyay S, Merid SK, Palmer CN, Pino-Yanes M, Pirmohamed M, Potočnik U, Repnik K, Schieck M, Sevelsted A, Sio YY, Smyth RL, Soares P, Söderhäll C, Tantisira KG, Tavendale R, Tse SM, Turner S, Verhamme KM, Maitland-van der Zee AH.

Allergy. 2018 Oct;73(10):2083-2088. doi: 10.1111/all.13499. Epub 2018 Jul 9. No abstract available.

16.

Variants in genes coding for glutathione S-transferases and asthma outcomes in children.

Turner S, Francis B, Wani N, Vijverberg S, Pino-Yanes M, Mukhopadhyay S, Tavendale R, Palmer C, Burchard EG, Merid SK, Melén E, Maitland-van der Zee AH, The Pharmacogenomics In Childhood Asthma Consortium OBO.

Pharmacogenomics. 2018 Jun 1;19(8):707-713. doi: 10.2217/pgs-2018-0027. Epub 2018 May 22.

PMID:
29785881
17.

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, Souverein PC, Keeman R, de Mutsert R, Noordam R, Rosendaal FR, Stringa N, Mook-Kanamori DO, Vaartjes I, Kiemeney LA, den Heijer M, van Schoor NM, Klungel OH, Maitland-Van der Zee AH, Schmidt MK, Polderman TJC, van der Leij AR, Posthuma D, Derks EM.

Drug Alcohol Depend. 2018 Jul 1;188:94-101. doi: 10.1016/j.drugalcdep.2018.03.026. Epub 2018 Apr 25.

18.

What do we need to transfer pharmacogenetics findings into the clinic?

Slob EMA, Vijverberg SJH, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH.

Pharmacogenomics. 2018 May;19(7):589-592. doi: 10.2217/pgs-2018-0026. Epub 2018 Apr 27. No abstract available.

19.

NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands.

van den Heuvel JM, Hövels AM, Büller HR, Mantel-Teeuwisse AK, de Boer A, Maitland-van der Zee AH.

Thromb J. 2018 Apr 18;16:7. doi: 10.1186/s12959-017-0156-y. eCollection 2018.

20.

Blood biomarkers in chronic airways diseases and their role in diagnosis and management.

van Bragt JJMH, Vijverberg SJH, Weersink EJM, Richards LB, Neerincx AH, Sterk PJ, Bel EHD, Maitland-van der Zee AH.

Expert Rev Respir Med. 2018 May;12(5):361-374. doi: 10.1080/17476348.2018.1457440. Epub 2018 Mar 29. Review.

PMID:
29575948

Supplemental Content

Loading ...
Support Center